166 related articles for article (PubMed ID: 23574628)
1. Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene.
Yamada R; Takahashi A; Torigoe T; Morita R; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Watarai K; Kondo T; Hirohashi Y; Sato N
Tissue Antigens; 2013 Jun; 81(6):428-34. PubMed ID: 23574628
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population.
Mori T; Nishizawa S; Hirohashi Y; Torigoe T; Tamura Y; Takahashi A; Kochin V; Fujii R; Kondo T; Greene MI; Hara I; Sato N
Exp Mol Pathol; 2012 Feb; 92(1):27-32. PubMed ID: 22001602
[TBL] [Abstract][Full Text] [Related]
3. Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
Takaya A; Hirohashi Y; Murai A; Morita R; Saijo H; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Takemasa I; Kondo T; Sato N; Torigoe T
PLoS One; 2016; 11(7):e0158903. PubMed ID: 27415781
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
[TBL] [Abstract][Full Text] [Related]
5. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.
Asano T; Hirohashi Y; Torigoe T; Mariya T; Horibe R; Kuroda T; Tabuchi Y; Saijo H; Yasuda K; Mizuuchi M; Takahashi A; Asanuma H; Hasegawa T; Saito T; Sato N
Oncotarget; 2016 Mar; 7(10):11223-37. PubMed ID: 26849232
[TBL] [Abstract][Full Text] [Related]
6. HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells.
Nishizawa S; Hirohashi Y; Torigoe T; Takahashi A; Tamura Y; Mori T; Kanaseki T; Kamiguchi K; Asanuma H; Morita R; Sokolovskaya A; Matsuzaki J; Yamada R; Fujii R; Kampinga HH; Kondo T; Hasegawa T; Hara I; Sato N
Cancer Res; 2012 Jun; 72(11):2844-54. PubMed ID: 22552285
[TBL] [Abstract][Full Text] [Related]
7. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.
Horibe R; Hirohashi Y; Asano T; Mariya T; Suzuki T; Takaya A; Saijo H; Shionoya Y; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Watanabe K; Atsuyama E; Toji S; Hirano H; Hasegawa T; Takahashi H; Sato N; Torigoe T
PLoS One; 2017; 12(3):e0171460. PubMed ID: 28248963
[TBL] [Abstract][Full Text] [Related]
8. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
[TBL] [Abstract][Full Text] [Related]
9. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
[TBL] [Abstract][Full Text] [Related]
10. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.
Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N
Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638
[TBL] [Abstract][Full Text] [Related]
11. DNA methyltransferase 1 is essential for initiation of the colon cancers.
Morita R; Hirohashi Y; Suzuki H; Takahashi A; Tamura Y; Kanaseki T; Asanuma H; Inoda S; Kondo T; Hashino S; Hasegawa T; Tokino T; Toyota M; Asaka M; Torigoe T; Sato N
Exp Mol Pathol; 2013 Apr; 94(2):322-9. PubMed ID: 23064049
[TBL] [Abstract][Full Text] [Related]
12. The cancer/testis genes: review, standardization, and commentary.
Scanlan MJ; Simpson AJ; Old LJ
Cancer Immun; 2004 Jan; 4():1. PubMed ID: 14738373
[TBL] [Abstract][Full Text] [Related]
13. [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery].
Wang Y; Liang Z; Yuan YH; Han Y; Liu YX; Liu N; Chen YT; Ritter G; Old LJ; Zhang LJ
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):464-8. PubMed ID: 15061963
[TBL] [Abstract][Full Text] [Related]
14. Ectopically expressed variant form of sperm mitochondria-associated cysteine-rich protein augments tumorigenicity of the stem cell population of lung adenocarcinoma cells.
Takahashi A; Hirohashi Y; Torigoe T; Tamura Y; Tsukahara T; Kanaseki T; Kochin V; Saijo H; Kubo T; Nakatsugawa M; Asanuma H; Hasegawa T; Kondo T; Sato N
PLoS One; 2013; 8(11):e69095. PubMed ID: 24244262
[TBL] [Abstract][Full Text] [Related]
15. MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells.
Yin B; Zeng Y; Liu G; Wang X; Wang P; Song Y
Int J Clin Exp Pathol; 2014; 7(6):2934-41. PubMed ID: 25031712
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features.
Ghafouri-Fard S; Abbasi A; Moslehi H; Faramarzi N; Taba Taba Vakili S; Mobasheri MB; Modarressi MH
Br J Dermatol; 2010 Apr; 162(4):772-9. PubMed ID: 19886887
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of cancer testis antigen genes in glioma stem cells.
Yawata T; Nakai E; Park KC; Chihara T; Kumazawa A; Toyonaga S; Masahira T; Nakabayashi H; Kaji T; Shimizu K
Mol Carcinog; 2010 Jun; 49(6):532-44. PubMed ID: 20082319
[TBL] [Abstract][Full Text] [Related]
18. Identification of cancer/testis-antigen genes by massively parallel signature sequencing.
Chen YT; Scanlan MJ; Venditti CA; Chua R; Theiler G; Stevenson BJ; Iseli C; Gure AO; Vasicek T; Strausberg RL; Jongeneel CV; Old LJ; Simpson AJ
Proc Natl Acad Sci U S A; 2005 May; 102(22):7940-5. PubMed ID: 15905330
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]